Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-08

Clinical Trial Update: Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM) [NA]

View source ↗

Summary

This completed trial investigates whether ivabradine can modify levcromakalim-induced symptoms in individuals with migraine without aura.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVABRADINE

Snippet

Sponsor: Danish Headache Center | Conditions: Headache, Migraine Without Aura | NA | Status: COMPLETED